Peter Clifford Promoted to President and COO of Cantel

Peter Clifford, currently Executive Vice President and Chief Operating Officer, has been promoted to President and Chief Operating Officer of Cantel.

Peter Clifford will continue to report to George Fotiades, Chief Executive Officer, and be based in Little Falls, NJ.

Mr. Clifford’s primary responsibilities will include continued oversight of Cantel’s overall business operations, close partnership with divisional and regional leaders to drive commercial results and the implementation and success of Cantel 2.0.

“Over the past sixteen months, Peter has distinguished himself as EVP and COO. He has demonstrated exceptional leadership of our actions to address the impact of the COVID crisis and has been an invaluable partner to me in setting the direction for Cantel 2.0 and its growth programs. This promotion not only recognizes his record of accomplishment, but his passion for the Company and advocacy of our core values,” said George Fotiades, CEO.

With more than 25 years of experience across manufacturing and industrial industries, Mr. Clifford brings strong operational discipline and financial acumen to the role. He previously served as Cantel’s EVP and COO, and prior to that over 4 years as EVP and Chief Financial Officer. Prior to joining Cantel, he served as Vice President of Operations, Finance, and Information Technology of IDEX Corporation, and held various senior financial positions for General Electric.  He holds an MBA from Northern Illinois University, a BS in Accounting from Eastern Illinois University, and is a Senior Executive Program (SEP) graduate from the Stanford University Graduate School of Business.

SourceCantel

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”